NCT02095080

Brief Summary

Amino acid are the building blocks of the body's protein. Some amino acids, including leucine, cannot be made in the body and must be obtained from diet, these are called essential. With increase in age the body's muscle mass decrease and studies have suggested that dietary supplementation of leucine may have potential health benefits in elderly in regards to prevention of age related loss of lean muscle mass, and thus may help improve the quality of life in elderly. Currently, a safe upper dietary intake level of leucine has not been established for healthy elderly. Prior to exploring whether leucine supplementation will prevent or decrease loss of lean muscle mass in elderly we propose to identify the upper intake of leucine in healthy elderly. The purpose of this study is to determine the tolerable upper intake level (UL) of leucine in healthy elderly men (70 - 75 yrs) The investigators hypothesize that with a careful graded stepwise increase in leucine intake in elderly men, above the Estimated Average Requirement (EAR - 50 mg/kg/d), the body's ability to oxidize/dispose of excess amino acids will reach a maximum. With increased leucine intakes we hypothesize an increase in plasma ammonia concentrations and increases in plasma leucine and urinary leucine excretion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 24, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

July 18, 2017

Status Verified

July 1, 2017

Enrollment Period

10 months

First QC Date

March 19, 2014

Last Update Submit

July 13, 2017

Conditions

Keywords

LeucineUpper Intake Level (UL)ElderlyAmino acidsProtein

Outcome Measures

Primary Outcomes (1)

  • 13 carbon dioxide production

    Urine, plasma and breath samples will be collected during the study to measure the rate of oxidation of the tracer.

    8 hours (1 study day)

Study Arms (1)

Leucine intake

EXPERIMENTAL

Dietary supplement: Leucine intake

Dietary Supplement: Leucine intake

Interventions

Leucine intakeDIETARY_SUPPLEMENT

Oral consumption of eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.

Leucine intake

Eligibility Criteria

Age70 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Men 70 - 75 years of age
  • Free of chronic diseases including; sarcopenia, heart disease, kidney disorders, liver disease, chronic high blood pressure and or diabetes.
  • Free of any cognitive disorders
  • Men not enrolled in any other research studies
  • Men who are not claustrophobic

You may not qualify if:

  • Men not within the age 70 -75 years
  • Men diagnosed with a chronic diseases including; sarcopenia, heart disease, kidney disorders, liver disease, chronic high blood pressure and/or diabetes
  • Men allergic to milk, eggs and egg protein
  • Men who are claustrophobic
  • Men who are currently enrolled in other research studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child & Family Research Institute

Vancouver, British Columbia, V5Z 4H4, Canada

Location

Related Publications (1)

  • Rasmussen B, Gilbert E, Turki A, Madden K, Elango R. Determination of the safety of leucine supplementation in healthy elderly men. Amino Acids. 2016 Jul;48(7):1707-16. doi: 10.1007/s00726-016-2241-0. Epub 2016 Apr 30.

Study Officials

  • Rajavel Elango, PhD

    Child & Family Research Institute/University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

March 19, 2014

First Posted

March 24, 2014

Study Start

August 1, 2014

Primary Completion

June 1, 2015

Study Completion

December 1, 2015

Last Updated

July 18, 2017

Record last verified: 2017-07

Locations